Lung Cancer
Gefitinib used to treat non-small cell lung cancer
Published in Cancer Weekly, January 31st, 2006
"Gefitinib is effective in the treatment of advanced NSCLC. However, most studies have only investigated patients who have good performance status or are evaluable," scientists in Taiwan reported.
"This study evaluated the efficacy of gefitinib in a consecutive series of patients with NSCLC. The treatment response of all gefitinib-treated NSCLC patients from November 2001 to September 2003 at a single medical institute was retrospectively evaluated. All patients receiving at least 1 dose of gefitinib...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-01-31)
More Articles from Cancer Weekly
- Cancer Drugs
New class of platinum-based antitumorals may improve outcomes in cancer patients - Cancer Research
Study shows tumor cells bordering normal tissue receive signals to wander - Cancer Risk Factors
Environmental factors accelerated evolution of extensive intestinal metaplasia - Cancer Therapy
Ovarian function suppression appears comparable to chemotherapy in young women - Glioblastoma Multiforme
Chromosome 7 conferred radiation resistance in human glioblastoma multiforme - Lung Cancer
Cancer-testis genes associated with poor outcome in non-small cell lung cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
